InteloMed, Inc.

InteloMed, Inc. is a biotechnology and medical devices startup that aims to revolutionize patient monitoring and informatics with its CVInsight® Patient Monitoring & Informatics Platform. The company was established in 2005 and received a Convertible Note investment on 30 April 2018. InteloMed focuses on providing non-invasive, real-time patient monitoring solutions, positioning itself as an advanced alternative to invasive and spot check approaches. Its CVInsight® System aims to deliver relevant and actionable health information for at-risk patients throughout the care pathway. With a strong focus on the healthcare and biotechnology sectors, InteloMed offers potential for disruption and innovation in patient care.